These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 12165635)
21. Proliferative lesions of oviduct and uterus in CD-1 mice exposed prenatally to tamoxifen. Diwan BA; Anderson LM; Ward JM Carcinogenesis; 1997 Oct; 18(10):2009-14. PubMed ID: 9364013 [TBL] [Abstract][Full Text] [Related]
22. Tamoxifen ruling in California. Mack T Science; 1995 Nov; 270(5239):1102-3. PubMed ID: 7502022 [No Abstract] [Full Text] [Related]
23. [Tamoxifen and endometrial cancer]. Salamanca-Gómez F Gac Med Mex; 2006; 142(2):171-2. PubMed ID: 16711554 [No Abstract] [Full Text] [Related]
24. Endometrial carcinoma and tamoxifen: clearing up a controversy. Andersson M; Storm HH; Mouridsen HT Clin Cancer Res; 1996 Jan; 2(1):223-4. PubMed ID: 9816110 [No Abstract] [Full Text] [Related]
25. The effects of tamoxifen on the uterus. Ismail SM Curr Opin Obstet Gynecol; 1996 Feb; 8(1):27-31. PubMed ID: 8777254 [TBL] [Abstract][Full Text] [Related]
26. High Incidence of Carcinosarcoma among Patients Previously Treated with Tamoxifen. Segev Y; Arnon E; Siegler E; Gemer O; Goldberg Y; Auslender R; Kaldawy A; Lavie O Isr Med Assoc J; 2017 Mar; 19(3):164-167. PubMed ID: 28457094 [TBL] [Abstract][Full Text] [Related]
28. Endometrial carcinoma can develop in patients on tamoxifen therapy. Omar SZ; Sivanesaratnam V Med J Malaysia; 1999 Jun; 54(2):280-2. PubMed ID: 10972045 [No Abstract] [Full Text] [Related]
29. Should we discontinue tamoxifen in a patient with vision-threatening ocular toxicity related to low-dose tamoxifen therapy? Tsai DC; Chen SJ; Chiou SH; Lee AF; Lee FL; Hsu WM Eye (Lond); 2003 Mar; 17(2):276-8. PubMed ID: 12640432 [No Abstract] [Full Text] [Related]
31. Tamoxifen and the uterus and endometrium. Cano A; Matallin P; Legua V; Tortajada M; Bonilla-Musoles F Lancet; 1989 Feb; 1(8634):376. PubMed ID: 18446930 [No Abstract] [Full Text] [Related]
32. The beneficial effect of the estrogen antagonist tamoxifen on experimental systemic lupus erythematosus. Thylan S J Rheumatol; 1995 Aug; 22(8):1606-7. PubMed ID: 7473493 [No Abstract] [Full Text] [Related]
33. Delayed severe hypertriglyceridemia from tamoxifen. Kanel KT; Wolmark N; Thompson PD N Engl J Med; 1997 Jul; 337(4):281. PubMed ID: 9229698 [No Abstract] [Full Text] [Related]
34. Myxoid leiomyosarcoma of the uterus in a patient receiving tamoxifen therapy: a case report. Botsis D; Koliopoulos C; Kondi-Pafitis A; Creatsas G Int J Gynecol Pathol; 2006 Apr; 25(2):173-5. PubMed ID: 16633068 [TBL] [Abstract][Full Text] [Related]
35. Endometrial cancers from tamoxifen are not more aggressive. Ziegler J J Natl Cancer Inst; 1996 Aug; 88(16):1101. PubMed ID: 8757186 [No Abstract] [Full Text] [Related]
36. Should tamoxifen users be screened for endometrial lesions? Neven P; Vergote I Lancet; 1998 Jan; 351(9097):155-7. PubMed ID: 9449866 [No Abstract] [Full Text] [Related]
37. A case of tamoxifen keratopathy. Zinchuk O; Watanabe M; Hayashi N; Fukushima A; Ueno H Arch Ophthalmol; 2006 Jul; 124(7):1046-8. PubMed ID: 16832031 [No Abstract] [Full Text] [Related]